Breath volatile analysis from patients diagnosed with harmful drinking, cirrhosis and hepatic encephalopathy: A pilot study

Metabolomics

Volumn 9, Issue 5, 2013, Pages 938-948

  Khalid, Tanzeela Yasmin ^a,b   Costello, Ben De Lacy ^b   Ewen, Richard ^b   White, Paul ^b   Stevens, Simon ^b   Gordon, Fiona ^c   Collins, Peter ^c   McCune, Anne ^c   Shenoy, Achuth ^c,d   Shetty, Sharan ^c,e   Ratcliffe, Norman Mark ^b   Probert, Chris Simon ^a,f  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b UNIVERSITY OF THE WEST OF ENGLAND   (United Kingdom)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^d IPSWICH HOSPITAL NHS TRUST   (United Kingdom)

^e DUDLEY GROUP OF HOSPITALS NHS TRUST   (United Kingdom)

^f BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Breath test; Gas chromatography; Hepatic encephalopathy; Liver; Mass spectrometry; Volatile organic compound

Indexed keywords

ADSORBENT; ALCOHOL; VOLATILE ORGANIC COMPOUND;

ADULT; AGED; ALCOHOL INTOXICATION; ALCOHOL LIVER CIRRHOSIS; ANALYTICAL EQUIPMENT; ARTICLE; BREATH ANALYSIS; CHEMICAL ANALYSIS; CLINICAL ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DESORPTION; DIAGNOSTIC TEST ACCURACY STUDY; DISCRIMINANT ANALYSIS; DISEASE CLASSIFICATION; DRINKING BEHAVIOR; FEMALE; HEPATIC ENCEPHALOPATHY; HOSPITAL CARE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; MULTIVARIATE ANALYSIS; PILOT STUDY; PREDICTION; SENSITIVITY AND SPECIFICITY;

EID: 84884414061     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-013-0510-4     Document Type: Article

References (48)

1. Adrover, R., Cocozzella, D., Ridruejo, E., Garcia, A., Rome, J., & Podesta, J. J. (2012). Breath-ammonia testing of healthy subjects and patients with cirrhosis. Digestive Diseases and Sciences, 57(1), 189-195.
2. Al Mardini, H., Bartlett, K., & Record, C. O. (1984). Blood and brain concentrations of mercaptans in hepatic and methanethiol induced coma. Gut, 25(3), 284-290.
3. Ali, Z., Thomas, C. L. P., & Alder, J. F. (1989). Denuder tubes for sampling of gaseous species. A review. Analyst, 114(7), 759-769.
4. Altman, D. G. (1991). Practical statistics for medical research (1st ed.). London: Chapman and Hall.
5. Amann, A., & Smith, D. (2005). Breath analysis for clinical diagnosis and therapeutic monitoring. Singapore: World Scientific Publishing.
6. American Thoracic Society & European Respiratory Society. (2005). ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. American Journal of Respiratory and Critical Care Medicine, 171(8), 912-930.
7. Angueira, C. E., & Kadakia, S. C. (1994). Effects of large-volume paracentesis on pulmonary function in patients with tense cirrhotic ascites. Hepatology, 20(4 Pt 1), 825-828.
8. Bender, R., & Lange, S. (2001). Adjusting for multiple testing-when and how? Journal of Clinical Epidemiology, 54(4), 343-349.
9. Blom, H. J., & Tangerman, A. (1988). Methanethiol metabolism in whole blood. Journal of Laboratory and Clinical Medicine, 111(6), 606-610.
10. Bode, C., & Bode, J. C. (1997). Alcohol's role in gastrointestinal tract disorders. Alcohol Health and Research World, 21(1), 76-83.
11. Bustamante, J., Rimola, A., Ventura, P. J., et al. (1999). Prognostic significance of hepatic encephalopathy in patients with cirrhosis. Journal of Hepatology, 30(5), 890-895.
12. Chen, S., Mahadevan, V., & Zieve, L. (1970). Volatile fatty acids in the breath of patients with cirrhosis of the liver. Journal of Laboratory and Clinical Medicine, 75(4), 622-627.
13. Chen, S. J., Wang, L. J., Zhu, Q., Cai, J. T., Chen, T., & Si, J. M. (2008). Effect of H pylori infection and its eradication on hyperammo-nemia and hepatic encephalopathy in cirrhotic patients. World Journal of Gastroenterology, 14(12), 1914-1918.
14. Dadamio, J., van den Velde, S., Laleman, W., van Hee, P., Coucke, W., et al. (2012). Breath biomarkers of liver cirrhosis. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 905, 17-22.
15. Davies, S. C. (2012). Annual Report of the Chief Medical Officer, Volume One, 2011, On the State of the Public's Health.
16. Degano, B., Mittaine, M., Guenard, H., et al. (2009). Nitric oxide and carbon monoxide lung transfer in patients with advanced liver cirrhosis. Journal of Applied Physiology, 107(1), 139-143.
17. Dhiman, R. K., Saraswat, V. A., Verma, M., & Naik, S. R. (1995). Figure connection test: A universal test for assessment of mental state. Journal of Gastroenterology and Hepatology, 10(1), 14-23.
18. DuBois, S., Eng, S., Bhattacharya, R., et al. (2005). Breath ammonia testing for diagnosis of hepatic encephalopathy. Digestive Diseases and Sciences, 50(10), 1780-1784.
19. Fisher, R. A. (1936). The use of multiple measurements in taxonomic problems. Annals of Eugenics, 7, 179-188.
20. Ford, A. C., Spiegel, B. M., Talley, N. J., & Moayyedi, P. (2009). Small intestinal bacterial overgrowth in irritable bowel syndrome: Systematic review and meta-analysis. Clinical Gastroenterology and Hepatology, 7(12), 1279-1286.
21. Fukui, H., Brauner, B., Bode, J. C., & Bode, C. (1991). Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease: Reevaluation with an improved chromogenic assay. Journal of Hepatology, 12(2), 162-169.
22. Gallego, E., Roca, F. X., Perales, F., Ribes, A., Carrera, G., Guardino, X., et al. (2007). Isocyanatocyclohexane and isothiocyanatocyclohexane levels in urban and industrial areas and possible emission-related activities. Atmospheric Environment, 41(37), 8228-8240.
23. Gitlin, N., Lewis, D. C., & Hinkley, L. (1986). The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. Journal of Hepatology, 3(1), 75-82.
24. Goldberg, E. M., Blendis, L. M., & Sandler, S. (1981). A gas chromatographic-mass spectrometric study of profiles of volatile metabolites in hepatic encephalopathy. Journal of Chromatography, 226(2), 291-299.
25. Hourani, J. M., Bellamy, P. E., Tashkin, D. P., Batra, P., & Simmons, M. S. (1991). Pulmonary dysfunction in advanced liver disease: Frequent occurrence of an abnormal diffusing capacity. American Journal of Medicine, 90(6), 693-700.
26. Kaji, H., Hisamura, M., Saito, N., & Murao, M. (1978). Evaluation of volatile sulfur compounds in the expired alveolar gas in patients with liver cirrhosis. Clinica Chimica Acta, 85(3), 279-284.
27. Landis, J. R., & Koch, G. G. (1977). The measurement of observer agreement for categorical data. Biometrics, 33(1), 159-174.
28. Lieber, C. S. (1997). Ethanol metabolism, cirrhosis and alcoholism. Clinica Chimica Acta, 257(1), 59-84.
29. Martinez, G. P., Barbera, J. A., Visa, J., et al. (2001). Hepatopulmonary syndrome in candidates for liver transplantation. Journal of Hepatology, 34(5), 651-657.
30. McClain, C. J., Zieve, L., Doizaki, W. M., Gilberstadt, S., & Onstad, G. R. (1980). Blood methanethiol in alcoholic liver disease with and without hepatic encephalopathy. Gut, 21(4), 318-323.
31. Millonig, G., Praun, S., Netzer, M., et al. (2010). Non-invasive diagnosis of liver diseases by breath analysis using an optimized ion-molecule reaction-mass spectrometry approach: A pilot study. Biomarkers, 15(4), 297-306.
32. Moscarella, S., Laffi, G., Buzzelli, G., Mazzanti, R., Caramelli, L., & Gentilini, P. (1984). Expired hydrocarbons in patients with chronic liver disease. Hepato-Gastroenterology, 31(2), 60-63.
33. Mudd, S. H., Levy, H. L., Tangerman, A., et al. (1995). Isolated persistent hypermethioninemia. American Journal of Human Genetics, 57(4), 882-892.
34. Mullen, K. D. (2007). Review of the final report of the 1998 Working Party on definition, nomenclature and diagnosis of hepatic encephalopathy. Alimentary Pharmacology & Therapeutics, 25(Suppl 1), 11-16.
35. Ong, J. P., Aggarwal, A., Krieger, D., et al. (2003). Correlation between ammonia levels and the severity of hepatic encephalopathy. American Journal of Medicine, 114(3), 188-193.
36. Probert, C. S. J., Ahmed, I., Khalid, T., Johnson, E., Smith, S., & Ratcliffe, N. (2009). Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases. Journal of Gastrointestinal and Liver Diseases, 18(3), 337-343.
37. Purohit, V. (2000). Can alcohol promote aromatization of androgens to estrogens? A review. Alcohol, 22(3), 123-127.
38. Quero, J. C., & Schalm, S. W. (1996). Subclinical hepatic encephalopathy. Seminars in Liver Disease, 16(3), 321-328.
39. Rodriguez-Roisin, R., & Krowka, M. J. (2008). Hepatopulmonary syndrome-a liver-induced lung vascular disorder. New England Journal of Medicine, 358(22), 2378-2387.
40. Smith, D., Wang, T., Pysanenko, A., & Spanel, P. (2008). A selected ion flow tube mass spectrometry study of ammonia in mouth- and nose-exhaled breath and in the oral cavity. Rapid Communications in Mass Spectrometry, 22(6), 783-789.
41. Solga, S. F., Alkhuraishe, A., Cope, K., et al. (2006). Breath biomarkers and non-alcoholic fatty liver disease: Preliminary observations. Biomarkers, 11(2), 174-183.
42. Spanel, P., Turner, C., Wang, T., Bloor, R., & Smith, D. (2006). Generation of volatile compounds on mouth exposure to urea and sucrose: Implications for exhaled breath analysis. Physiological Measurement, 27(2), N7-N17.
43. Tan, H. H., Lee, G. H., Thia, K. T., Ng, H. S., Chow, W. C., & Lui, H. F. (2009). Minimal hepatic encephalopathy runs a fluctuating course: Results from a three-year prospective cohort follow-up study. Singapore Medical Journal, 50(3), 255-260.
44. Tangerman, A., Meuwese-Arends, M. T., & Jansen, J. B. (1994). Cause and composition of foetor hepaticus. Lancet, 343(8895), 483.
45. Tangerman, A., Meuwese-Arends, M. T., & van Tongeren, J. H. (1983). A new sensitive assay for measuring volatile sulphur compounds in human breath by Tenax trapping and gas chromatography and its application in liver cirrhosis. Clinica Chimica Acta, 130(1), 103-110.
46. Tangerman, A., & Winkel, E. G. (2007). Intra- and extra-oral halitosis: Finding of a new form of extra-oral blood-borne halitosis caused by dimethyl sulphide. Journal of Clinical Periodontology, 34(9), 748-755.
47. van Berkel, J. J., Dallinga, J. W., Moller, G. M., et al. (2008). Development of accurate classification method based on the analysis of volatile organic compounds from human exhaled air. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 861(1), 101-107.
48. van den Velde, S., Nevens, F., van Hee, P., van Steenberghe, D., & Quirynen, M. (2008). GC-MS analysis of breath odor compounds in liver patients. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 875(2), 344-348.